th chemically synthesized cannabinoids or cannabinoid-like compounds, but has never approved a drug derived from the cannabis plant. In October 2017, U.K.-based GW Pharmaceuticals submitted a New Drug Application (NDA) to the FDA for Epidio- lex, an oral formulation of cannabis-derived cannabidiol, or CBD, in

) boosted its full-year profit forecast, with the U.K.-based publisher saying pressures on its North American

30px; min-width: 100%;"> Uber will reclassify all U.K.-based drivers as workers, in the wake of losing a major